Status:
RECRUITING
Study of Parameters of Osteosarcopenia in Patients With Hip Fracture
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Osteoporotic Fracture of Femur
Osteoarthritis, Hip
Eligibility:
All Genders
65+ years
Brief Summary
The study aims to assess the adequacy of a set of clinical and laboratory investigations for identifying the osteosarcopenia status in patients undergoing a hip replacement for a fragility fracture of...
Detailed Description
Osteoporotic hip fractures (fragility fractures) are common in older adults, and the risk of adverse outcomes and mortality is higher in patients affected by osteosarcopenia, a geriatric syndrome in w...
Eligibility Criteria
Inclusion
- Patients who came to observation with femoral neck fracture of possible osteoporotic nature (no or minimal trauma) to be treated with endoprosthesis or hip arthroplasty.
- Competent patients who have signed consent to participate in the study (see Informed Consent section of this protocol).
Exclusion
- Previous osteoporotic fractures
- Previous prosthetic surgery for orthopedic diseases
- Pre-existing clinical conditions that led to permanent immobility
- Neoplastic diseases
- Autoimmune diseases
- Severe myopathies
- Chronic viral infections (HBV, HCV, HIV);
- Chronic treatment with anti-osteoporotic drugs, immunosuppressive drugs, and insulin
- Paget's disease
Key Trial Info
Start Date :
November 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04730622
Start Date
November 23 2020
End Date
December 31 2025
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ortopedico Rizzoli
Bologna, Italy, 40136